David A. Hinkle - Oct 11, 2024 Form 3 Insider Report for Boundless Bio, Inc. (BOLD)

Role
Sr. VP, Finance, Controller, Treasurer Exhibit 24 - Power of Attorney.
Signature
/s/ Jessica Oien, Attorney- in-Fact for David A. Hinkle
Stock symbol
BOLD
Transactions as of
Oct 11, 2024
Transactions value $
$0
Form type
3
Date filed
10/15/2024, 08:05 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BOLD Common Stock 100 Oct 11, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BOLD Stock Option Oct 11, 2024 Common Stock 21.8K Direct F1, F8, F9
holding BOLD Stock Option Oct 11, 2024 Common Stock 9.64K Direct F2, F8, F9
holding BOLD Stock Option Oct 11, 2024 Common Stock 10.3K Direct F3, F8, F9
holding BOLD Stock Option Oct 11, 2024 Common Stock 23.1K Direct F4, F8, F9
holding BOLD Stock Option Oct 11, 2024 Common Stock 12.8K Direct F5, F8, F9
holding BOLD Stock Option Oct 11, 2024 Common Stock 22.7K Direct F6, F8, F9
holding BOLD Stock Option Oct 11, 2024 Common Stock 13.9K Direct F7, F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 25% of the underlying shares on June 1, 2022, and vests as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.
F2 The stock option vests in 48 substantially equal monthly installments of the original number of underlying shares, which was 9,742 shares. The first installment vested on July 7, 2021. Prior to October 11, 2024, the reporting person partially exercised the stock option and purchased 100 of the underlying shares which had vested.
F3 The stock option vests in 48 substantially equal monthly installments. The first installment vested on January 6, 2022.
F4 The stock option vests in 48 substantially equal monthly installments. The first installment vested on July 13, 2023.
F5 The stock option vests in 48 substantially equal monthly installments. The first installment vested on July 13, 2023.
F6 The stock option vests in 48 substantially equal monthly installments. The first installment vested on March 15, 2024.
F7 The stock option vests in 48 substantially equal monthly installments. The first installment vested on April 27, 2024.
F8 The issuer repriced the stock option on August 19, 2024 (the "Repricing Date"). As of the Repricing Date, the exercise price was reduced to $3.56 per share, representing the fair market value per share of the issuer's common stock on the Repricing Date; provided, however, that the original exercise price before the repricing will apply if, prior to the Premium End Date (as defined below), the stock option is exercised or the reporting person's employment terminates for any reason other than a Qualifying Termination (as defined below). The "Premium End Date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the reporting person's Qualifying Termination. A "Qualifying Termination" means (a) the involuntary termination of the reporting person's employment by the issuer due to a reduction in force (and other than for cause),
F9 (Continued from footnote 8) or (b) the reporting person's termination of employment due to death or disability. The original exercise price (before the repricing) of each stock option that expires in 2031 or 2033 was $4.10 per share. The original exercise price of the stock option that expires in February 2034 was $8.19 per share, and the original exercise price of the stock option that expires in March 2034 was $16.00 per share.

Remarks:

Sr. VP, Finance, Controller, Treasurer Exhibit 24 - Power of Attorney.